Secondary immunodeficiency in lymphoproliferative disorders

Cost-Effectiveness Analysis of Induction Regimens Containing Anthracyclines in Adult Acute Myelogenous Leukemia.

Leukemia & lymphoma·2016

P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival.

Hematology (Amsterdam, Netherlands)·2016

Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study).

Annals of hematology·2013

Development of JAK2V617F-positive polycythemia vera after chemotherapy-induced remission of primary central nervous system diffuse large B cell non-Hodgkin's lymphoma: a case report and review of the literature.

Acta haematologica·2013

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.

Leukemia·2010

Innate immune surveillance and nucleic acid sensing: Gatekeepers of inflammatory cell death in respiratory infectious diseases.

Pharmacological research·2026

Beyond Lipid Lowering: Targeting lncRNAs as a Novel Therapeutic Strategy for Vascular Wall Defense in Atherosclerosis.

Pharmacological research·2026

Engineered novel protease-stable multifunctional peptides attenuate metabolic dysfunction-associated steatotic liver disease via disrupting bile acid micelle and activating PPAR pathway.

Pharmacological research·2026

Targeting the APOE4-driven peripheral-central immune axis: A new frontier for Alzheimer's disease therapy.

Pharmacological research·2026

Targeting the pathological tau N368 fragment: A pharmacological perspective on a novel immunotherapy for Alzheimer's disease.

Pharmacological research·2026

Systematic review of antifibrotic effects of metformin: Insights from preclinical and clinical studies and potential relevance to oral submucous fibrosis.

Pharmacological research·2026

Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.

Case reports in dermatological medicine·2026

Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.

Frontiers in endocrinology·2026

Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.

Kidney diseases (Basel, Switzerland)·2026

Diffuse Large B-cell Lymphoma Initially Managed As Secondary Immune Thrombocytopenia: A Case Report.

Cureus·2026

Adverse pregnancy outcome associations among women prior to a diagnosis of systemic lupus erythematosus.

Frontiers in lupus·2026

Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.

Frontiers in cell and developmental biology·2026

Related Experiment Videos

Secondary immunodeficiency in lymphoproliferative disorders

Related Concept Videos

Cost-Effectiveness Analysis of Induction Regimens Containing Anthracyclines in Adult Acute Myelogenous Leukemia.

P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival.

Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study).

Development of JAK2V617F-positive polycythemia vera after chemotherapy-induced remission of primary central nervous system diffuse large B cell non-Hodgkin's lymphoma: a case report and review of the literature.

Primary plasma cell leukemia: a retrospective multicenter study of 73 patients.

BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.

Innate immune surveillance and nucleic acid sensing: Gatekeepers of inflammatory cell death in respiratory infectious diseases.

Beyond Lipid Lowering: Targeting lncRNAs as a Novel Therapeutic Strategy for Vascular Wall Defense in Atherosclerosis.

Engineered novel protease-stable multifunctional peptides attenuate metabolic dysfunction-associated steatotic liver disease via disrupting bile acid micelle and activating PPAR pathway.

Targeting the APOE4-driven peripheral-central immune axis: A new frontier for Alzheimer's disease therapy.

Targeting the pathological tau N368 fragment: A pharmacological perspective on a novel immunotherapy for Alzheimer's disease.

Systematic review of antifibrotic effects of metformin: Insights from preclinical and clinical studies and potential relevance to oral submucous fibrosis.

Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.

Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.

Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.

Diffuse Large B-cell Lymphoma Initially Managed As Secondary Immune Thrombocytopenia: A Case Report.

Adverse pregnancy outcome associations among women prior to a diagnosis of systemic lupus erythematosus.

Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.

Related Experiment Videos

Secondary immunodeficiency in lymphoproliferative disorders

Related Concept Videos

Related Articles